Selected:

Buy 5F-MN-18 drugs Online

320,00$5 200,00$

Buy 5F-MN-18 drugs Online

320,00$5 200,00$

MN 18 is an indazole-based synthetic cannabinoid that is an agonist for the cannabinoid receptors, with Ki values of 45.72 nM at CB1 and 11.098 nM at CB2 and EC50 values of 2.028 nM at CB1 and 1.233 nM at CB2, and has been sold online as a designer drug. It is the indazole core analogue of NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of MN-18 may release 1-naphthylamine, a known carcinogen. MN-18 metabolism has been described in literature.

100g
1kg
3kg
500g
50g
Clear
My favorite
My favorite
SKU: N/A Category:

Description

MN 18 is an indazole-based synthetic cannabinoid that is an agonist for the cannabinoid receptors, with Ki values of 45.72 nM at CB1 and 11.098 nM at CB2 and EC50 values of 2.028 nM at CB1 and 1.233 nM at CB2, and has been sold online as a designer drug. It is the indazole core analogue of NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of MN-18 may release 1-naphthylamine, a known carcinogen. MN-18 metabolism has been described in literature.

5f-MN-18 is derived from MN-18 and is often known only as MN-18 known also as 1-Pentyl-1H-indazole-3-carboxylic acid naphthalen-1-ylamide. The compound is a new cannabinoids that is based on changing indole of 5F-MN24 as Indazole. The formula is C24H23N2OF.

CAS: 763954-93-9
Formula: C23H22FN3O
Purity: 99,7% min
Molecular weight: 375.44

MN-18 is a synthetic cannabinoid modeled after AKB48 (APINACA, Item No. ISO00060), with the adamantyl group replaced by a naphthalenyl group. 5-fluoro MN-18 differs structurally from MN-18 by having fluorine at the terminal carbon of the pentyl chain. The physiological and toxicological properties of this compound are unknown. This product is intended for forensic and research applications.

MN 18 is an indazole-based synthetic cannabinoid that is an agonist for the cannabinoid receptors, with Ki values of 45.72 nM at CB1 and 11.098 nM at CB2 and EC50 values of 2.028 nM at CB1 and 1.233 nM at CB2, and has been sold online as a designer drug. It is the indazole core analogue of NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of MN-18 may release 1-naphthylamine, a known carcinogen. MN-18 metabolism has been described in literature.

Additional information

Quantity

, , , ,

Close Menu
×
×

Basket